Sage Therapeutics (SAGE) Q1 2025 Earnings

Feb 11Confirmed
Q1 2024
Q3 2024
Q4 2024
Q1 2025
-1.8
-1.69
-1.59
-1.48

Details

Expected EPS
-1.483264
Actual EPS
-1.56
Surprise EPS
-0.08
Surprise Percent
-5.17%

Description

⁨Sage Therapeutics⁩ (⁦SAGE⁩) has reported earnings of ⁦-1.56⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts